3 February 2023
Jeff Buck, Vice President, Adherence
1 February 2023
NICE has announced the approval
20 January 2023
Global leader in custom development
19 January 2023
UK-based provider of next-generation bioreactors
POPULAR NEWS ITEMS
21 December 2022
In this interview, Brandon McNaughton,
19 December 2022
Brian Hanrahan, Vice President of
14 December 2022
Global pharmaceutical company, Kite, a
23 November 2022
Late-stage clinical trial company CellVax
